Yuyu Pharma (000220) — Cash Flow-to-Debt Ratio
Yuyu Pharma (000220) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of ₩836.62 Million could theoretically repay 0% of its total liabilities (₩63.32 Billion) in one year. See 000220 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Yuyu Pharma Cash Flow-to-Debt Ratio (2011–2024)
Historical debt coverage capacity for Yuyu Pharma across 14 annual periods. Also explore Yuyu Pharma (000220) equity growth momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Yuyu Pharma (2011–2024)
Year-by-year debt coverage analysis for Yuyu Pharma. For market capitalisation and broader financial context, see 000220 market cap.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.34x | ₩24.95 Billion | ₩72.62 Billion | ▲ +6255.6% |
| 2023 | 0.01x | ₩420.86 Million | ₩77.86 Billion | ▲ +106.2% |
| 2022 | -0.09x | ₩-6.23 Billion | ₩71.83 Billion | ▼ -223.7% |
| 2021 | 0.07x | ₩4.51 Billion | ₩64.30 Billion | ▲ +199.5% |
| 2020 | -0.07x | ₩-2.67 Billion | ₩37.86 Billion | ▼ -125.2% |
| 2019 | 0.28x | ₩13.19 Billion | ₩47.17 Billion | ▲ +121.2% |
| 2018 | 0.13x | ₩6.11 Billion | ₩48.35 Billion | ▲ +770.2% |
| 2017 | 0.01x | ₩561.35 Million | ₩38.66 Billion | ▼ -95.1% |
| 2016 | 0.30x | ₩9.82 Billion | ₩33.01 Billion | ▲ +177.9% |
| 2015 | -0.38x | ₩-11.68 Billion | ₩30.60 Billion | ▼ -937.8% |
| 2014 | 0.05x | ₩1.36 Billion | ₩29.91 Billion | ▲ +241.1% |
| 2013 | -0.03x | ₩-775.17 Million | ₩23.99 Billion | ▼ -109.5% |
| 2012 | 0.34x | ₩6.51 Billion | ₩19.18 Billion | ▲ +8.2% |
| 2011 | 0.31x | ₩6.67 Billion | ₩21.28 Billion | — |